TrialBreast cancer research : BCR2020

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.

Christos Vaklavas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.